BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31790563)

  • 1. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
    Diaz-Galvan P; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Min HP; Jain M; Miyagawa T; Forsberg LK; Fields JA; Savica R; Graff-Radford J; Jones DT; Botha H; St Louis EK; Knopman DS; Ramanan VK; Ross O; Graff-Radford N; Day GS; Dickson DW; Ferman TJ; Petersen RC; Lowe VJ; Boeve BF; Kantarci K
    Neurology; 2023 Jul; 101(2):e178-e188. PubMed ID: 37202168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
    Gomperts SN; Locascio JJ; Makaretz SJ; Schultz A; Caso C; Vasdev N; Sperling R; Growdon JH; Dickerson BC; Johnson K
    JAMA Neurol; 2016 Nov; 73(11):1334-1341. PubMed ID: 27654968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
    Ferreira D; Przybelski SA; Lesnick TG; Schwarz CG; Diaz-Galvan P; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Jones DT; Savica R; Ferman TJ; Graff-Radford N; Lowe VJ; Jack CR; Petersen RC; Westman E; Boeve BF; Kantarci K
    Neurology; 2023 Feb; 100(8):e846-e859. PubMed ID: 36443011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Chen Q; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Graff-Radford J; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Parisi JE; Dickson DW; Petersen RC; Boeve BF; Murray ME
    Neurology; 2020 Jan; 94(3):e282-e291. PubMed ID: 31862783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
    Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
    Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.
    Petersen RC; Wiste HJ; Weigand SD; Rocca WA; Roberts RO; Mielke MM; Lowe VJ; Knopman DS; Pankratz VS; Machulda MM; Geda YE; Jack CR
    JAMA Neurol; 2016 Jan; 73(1):85-92. PubMed ID: 26595683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a [
    Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
    Neurology; 2023 Nov; 101(19):e1850-e1862. PubMed ID: 37748892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies.
    Chen Q; Przybelski SA; Senjem ML; Schwarz CG; Lesnick TG; Botha H; Knopman DS; Graff-Radford J; Savica R; Jones DT; Fields JA; Jain MK; Graff-Radford NR; Ferman TJ; Kremers WK; Jack CR; Petersen RC; Boeve BF; Lowe VJ; Kantarci K
    Mov Disord; 2022 Jun; 37(6):1256-1264. PubMed ID: 35261094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain β-amyloid load approaches a plateau.
    Jack CR; Wiste HJ; Lesnick TG; Weigand SD; Knopman DS; Vemuri P; Pankratz VS; Senjem ML; Gunter JL; Mielke MM; Lowe VJ; Boeve BF; Petersen RC
    Neurology; 2013 Mar; 80(10):890-6. PubMed ID: 23446680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
    Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
    JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.
    Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P
    JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.
    Ferreira D; Przybelski SA; Lesnick TG; Lemstra AW; Londos E; Blanc F; Nedelska Z; Schwarz CG; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Savica R; Ferman TJ; Graff-Radford NR; Lowe VJ; Jack CR; Petersen RC; Mollenhauer B; Garcia-Ptacek S; Abdelnour C; Hort J; Bonanni L; Oppedal K; Kramberger MG; Boeve BF; Aarsland D; Westman E; Kantarci K
    Neurology; 2020 Dec; 95(24):e3257-e3268. PubMed ID: 32989106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
    Gonzalez MC; Ashton NJ; Gomes BF; Tovar-Rios DA; Blanc F; Karikari TK; Mollenhauer B; Pilotto A; Lemstra A; Paquet C; Abdelnour C; Kramberger MG; Bonanni L; Vandenberghe R; Hye A; Blennow K; Zetterberg H; Aarsland D;
    JAMA Neurol; 2022 Jan; 79(1):32-37. PubMed ID: 34807233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study.
    Sullivan KJ; Liu A; Chang CH; Cohen AD; Lopresti BJ; Minhas DS; Laymon CM; Klunk WE; Aizenstein H; Nadkarni NK; Loewenstein D; Kamboh MI; Ganguli M; Snitz BE
    Brain Imaging Behav; 2021 Jun; 15(3):1355-1363. PubMed ID: 32748322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.
    Zeydan B; Lowe VJ; Reichard RR; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Parisi JE; Machulda MM; Vemuri P; Mielke MM; Knopman DS; Petersen RC; Jack CR; Kantarci OH; Kantarci K
    Ann Neurol; 2020 Apr; 87(4):556-567. PubMed ID: 31970802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.